US Oral Nicotine Pouch Sales and Taxes Under Academic Scrutiny

Tobacco Control BMJ recently published new research examining the landscape of modern oral nicotine products in the United States. The journal's "Online First" section includes studies detailing the continued increase in US retail sales of nicotine in oral nicotine pouches and e-cigarettes, alongside an analysis of excise taxes applied to oral nicotine pouches. These reports contribute to the ongoing academic discourse surrounding the market dynamics and regulatory considerations for these product categories.

A letter published on May 4, 2026, by Megan C Diaz, Adrian Bertrand, and Elizabeth C Hair, indicated that US retail sales of total kilograms of nicotine in oral nicotine pouches and e-cigarettes have continued to rise. Separately, an original research paper dated May 11, 2026, authored by Yanyun He, Patricia J Zettler, Micah L Berman, Lei Xu, and Ce Shang, focused on the specifics of excise taxes levied on oral nicotine pouches within the US market. These studies provide quantitative and policy-oriented insights into the evolving sector.

Further research from Tobacco Control BMJ, published on April 3, 2026, investigated consumer perceptions and use intentions related to ZYN, a modern oral nicotine pouch brand. This study, conducted by Haijing Ma, Jianfeng Zhang, and Hongying Daisy Dai, specifically analyzed the impact of Modified Risk Tobacco Product (MRTP) claims, nicotine strength, and nicotine labeling on adult smokers' views and potential usage of ZYN products. This highlights the academic community's interest in how product characteristics and regulatory claims influence consumer behavior.

In a related context concerning the interaction between the tobacco industry and the academic and health professional communities, TobaccoTactics.org reported on strategies employed by tobacco companies. These tactics include direct engagement with health professionals, funding academic medical centers and groups, and efforts to publish favorable research in journals. The report from TobaccoTactics.org, last updated February 20, 2026, cited instances such as Philip Morris's initiative with IBM and Swedish Match's (now owned by PMI) endowment of a chair at the University of Louisville. This broader perspective underscores the various influences at play in the research and public health discussions surrounding tobacco and nicotine products.

The collective findings from Tobacco Control BMJ's recent publications offer a multi-faceted view of the modern oral nicotine market in the US, encompassing sales growth, taxation, and consumer perceptions of specific products like ZYN. The academic scrutiny of these areas, coupled with the industry engagement practices highlighted by TobaccoTactics.org, indicates a complex environment where market expansion, regulatory frameworks, and scientific inquiry intersect. These reports provide data points for stakeholders monitoring the development and regulation of nicotine alternatives.